{
    "Participant": "hu0D1FA1", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=bda77d635594fb8e58841c523fb5d2cdcb64c9c0&access_token=f6d855f6778876a2356aa34dcd498409", 
    "Variants": [
        {
            "Allele Frequency": "0.052", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "52913668", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Skin"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KRT5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19578363"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "2", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).", 
            "URL": "http://evidence.pgp-hms.org/KRT5-G138E", 
            "Variant Name": "KRT5-G138E", 
            "Variant Page": "http://evidence.pgp-hms.org/KRT5-G138E", 
            "dbSNP IDs": [
                "rs11170164"
            ]
        }, 
        {
            "Allele Frequency": "0.45", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "7870973", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Metabolism", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MTRR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 7, 
            "PMID List": [
                "10444342", 
                "10930360", 
                "11807890", 
                "12375236", 
                "15060097", 
                "15979034", 
                "17024475"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.", 
            "URL": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "Variant Name": "MTRR-I49M", 
            "Variant Page": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "dbSNP IDs": [
                "rs1801394"
            ]
        }, 
        {
            "Allele Frequency": "0.4", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6303354", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Immune system", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Not Reviewed", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "17603484", 
                "17719176", 
                "23257691"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "4", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).", 
            "URL": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "Variant Name": "WFS1-R611H", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "dbSNP IDs": [
                "rs734312"
            ]
        }, 
        {
            "Allele Frequency": "0.0029", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182555149", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "11799394", 
                "15714208"
            ], 
            "Scores": {
                "Case/Control": "-1", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Implicated in causing familial prostate cancer, but later findings fail to confirm this. The variant is equally common in the control population, which strongly contradicts the original hypothesis of a high penetrance effect. If the variant has any effect on prostate cancer it seems likely to be low penetrance (any evidence for this is, however, very weak).", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-E265X", 
            "Variant Name": "RNASEL-E265X", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-E265X"
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "12915009", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ELAC2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "12384782", 
                "15368467", 
                "18767027", 
                "20231859"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).", 
            "URL": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "Variant Name": "ELAC2-S217L", 
            "Variant Page": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "dbSNP IDs": [
                "rs4792311"
            ]
        }, 
        {
            "Allele Frequency": "0.049", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "41858876", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGFB1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "8901839", 
                "14596813", 
                "15212689", 
                "15569360"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.", 
            "URL": "http://evidence.pgp-hms.org/TGFB1-R25P", 
            "Variant Name": "TGFB1-R25P", 
            "Variant Page": "http://evidence.pgp-hms.org/TGFB1-R25P", 
            "dbSNP IDs": [
                "rs1800471"
            ]
        }, 
        {
            "Allele Frequency": "0.044", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "223285200", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TLR5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "14623910", 
                "16027372", 
                "17516623", 
                "18230059"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.", 
            "URL": "http://evidence.pgp-hms.org/TLR5-R392X", 
            "Variant Name": "TLR5-R392X", 
            "Variant Page": "http://evidence.pgp-hms.org/TLR5-R392X", 
            "dbSNP IDs": [
                "rs5744168"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.31", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "9323910", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Genital and urinary", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "H6PD", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "12858176", 
                "15827106", 
                "16817821"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).", 
            "URL": "http://evidence.pgp-hms.org/H6PD-R453Q", 
            "Variant Name": "H6PD-R453Q", 
            "Variant Page": "http://evidence.pgp-hms.org/H6PD-R453Q", 
            "dbSNP IDs": [
                "rs6688832"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.063", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "10271087", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Genital and urinary", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CLEC7A", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "19864674"
            ], 
            "Scores": {
                "Case/Control": null, 
                "Computational": "4", 
                "Familial": "1", 
                "Functional": "2", 
                "Penetrance": "4", 
                "Severity": "1", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.", 
            "URL": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "Variant Name": "CLEC7A-Y238X", 
            "Variant Page": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "dbSNP IDs": [
                "rs16910526"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "26091179", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "HFE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "8696333", 
                "9462220", 
                "12429850", 
                "14673107", 
                "17042772"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.", 
            "URL": "http://evidence.pgp-hms.org/HFE-H63D", 
            "Variant Name": "HFE-H63D", 
            "Variant Page": "http://evidence.pgp-hms.org/HFE-H63D", 
            "dbSNP IDs": [
                "rs1799945"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "16251599", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCC6", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "10811882", 
                "10913334", 
                "11776382", 
                "20038957"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.", 
            "URL": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "Variant Name": "ABCC6-R1268Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "dbSNP IDs": [
                "rs2238472"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CCR5", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "8751444", 
                "8791590", 
                "8898752"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.", 
            "URL": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "Variant Name": "CCR5-S185Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "dbSNP IDs": [
                "rs333"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "21140432", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NPC1", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "19151714", 
                "19174833", 
                "19910939"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6\" individual).\n\n\n\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "Variant Name": "NPC1-H215R", 
            "Variant Page": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "dbSNP IDs": [
                "rs1805081"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "35874575", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "IL7R", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 5, 
            "PMID List": [
                "12825072", 
                "17660530", 
                "17660816", 
                "17660817", 
                "21161391"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a \"protective\" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).", 
            "URL": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "Variant Name": "IL7R-T244I", 
            "Variant Page": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "dbSNP IDs": [
                "rs6897932"
            ]
        }, 
        {
            "Allele Frequency": "0.084", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "19819724", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LPL", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "16574898", 
                "17463246", 
                "18193044", 
                "19802338", 
                "20429872", 
                "22042884"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.", 
            "URL": "http://evidence.pgp-hms.org/LPL-S474X", 
            "Variant Name": "LPL-S474X", 
            "Variant Page": "http://evidence.pgp-hms.org/LPL-S474X", 
            "dbSNP IDs": [
                "rs328"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "89017961", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 7, 
            "PMID List": [
                "1820207", 
                "7704033", 
                "11284711", 
                "18326704", 
                "18488027", 
                "18488028", 
                "19533789"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.", 
            "URL": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "Variant Name": "TYR-R402Q", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "dbSNP IDs": [
                "rs1126809"
            ]
        }, 
        {
            "Allele Frequency": "0.017", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "74757554", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "HTRA2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "15961413", 
                "18364387"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report proposed an association with increased risk for Parkinson's disease, but had very weak statistical significance. A later study found an equal incidence of this variant in cases and controls, contradicting any association with the disease.", 
            "URL": "http://evidence.pgp-hms.org/HTRA2-A141S", 
            "Variant Name": "HTRA2-A141S", 
            "Variant Page": "http://evidence.pgp-hms.org/HTRA2-A141S", 
            "dbSNP IDs": [
                "rs72470544"
            ]
        }, 
        {
            "Allele Frequency": "0.073", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "180057293", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "FLT4", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "11292664"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/FLT4-N149D", 
            "Variant Name": "FLT4-N149D", 
            "Variant Page": "http://evidence.pgp-hms.org/FLT4-N149D", 
            "dbSNP IDs": [
                "rs34221241"
            ]
        }, 
        {
            "Allele Frequency": "0.37", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "6026988", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "PMS2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15256438"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Benign, common variant.", 
            "URL": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "Variant Name": "PMS2-P470S", 
            "Variant Page": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "dbSNP IDs": [
                "rs1805321"
            ]
        }, 
        {
            "Allele Frequency": "0.016", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "15299051", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "NOTCH3", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign, seen in two healthy PGP participants.", 
            "URL": "http://evidence.pgp-hms.org/NOTCH3-P496L", 
            "Variant Name": "NOTCH3-P496L", 
            "Variant Page": "http://evidence.pgp-hms.org/NOTCH3-P496L", 
            "dbSNP IDs": [
                "rs11670799"
            ]
        }, 
        {
            "Allele Frequency": "0.038", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "100962156", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCCA", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "10101253"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported as a polymorphism, tentatively presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PCCA-I475V", 
            "Variant Name": "PCCA-I475V", 
            "Variant Page": "http://evidence.pgp-hms.org/PCCA-I475V", 
            "dbSNP IDs": [
                "rs35719359"
            ]
        }, 
        {
            "Allele Frequency": "0.024", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "78078656", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "GAA", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "16359900"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a rare but non-pathogenic coding polymorphism in GAA that creates variant allozyme, known as GAA*2.\n\n \n", 
            "URL": "http://evidence.pgp-hms.org/GAA-D91N", 
            "Variant Name": "GAA-D91N", 
            "Variant Page": "http://evidence.pgp-hms.org/GAA-D91N", 
            "dbSNP IDs": [
                "rs1800299"
            ]
        }, 
        {
            "Allele Frequency": "0.009", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "108397495", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FKTN", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/FKTN-N446D", 
            "Variant Name": "FKTN-N446D", 
            "Variant Page": "http://evidence.pgp-hms.org/FKTN-N446D", 
            "dbSNP IDs": [
                "rs41313301"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "152276772", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FLG", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.", 
            "URL": "http://evidence.pgp-hms.org/FLG-R3530S", 
            "Variant Name": "FLG-R3530S", 
            "Variant Page": "http://evidence.pgp-hms.org/FLG-R3530S", 
            "dbSNP IDs": [
                "rs72697000"
            ]
        }, 
        {
            "Allele Frequency": "0.046", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "41246481", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "BRCA1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "17341484", 
                "19661094"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One common variant associated this variant with an increased risk of breast cancer, but a more recent, larger study found no association.", 
            "URL": "http://evidence.pgp-hms.org/BRCA1-Q356R", 
            "Variant Name": "BRCA1-Q356R", 
            "Variant Page": "http://evidence.pgp-hms.org/BRCA1-Q356R", 
            "dbSNP IDs": [
                "rs1799950"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7906519", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "GUCY2D", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "8944027"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "Variant Name": "GUCY2D-A52S", 
            "Variant Page": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "dbSNP IDs": [
                "rs61749665"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.29", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68855363", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TPCN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "18488028"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Pigmentation allele.", 
            "URL": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "Variant Name": "TPCN2-G734E", 
            "Variant Page": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "dbSNP IDs": [
                "rs3829241"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "88911696", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "17952075", 
                "17999355"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).", 
            "URL": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "Variant Name": "TYR-S192Y", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "dbSNP IDs": [
                "rs1042602"
            ]
        }
    ]
}